Compare NNNN & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | ULCC |
|---|---|---|
| Founded | 2021 | 1994 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2017 |
| Metric | NNNN | ULCC |
|---|---|---|
| Price | $23.79 | $3.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $5.06 |
| AVG Volume (30 Days) | 26.3K | ★ 4.5M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,724,000,000.00 |
| Revenue This Year | N/A | $21.54 |
| Revenue Next Year | N/A | $12.20 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.91 | $2.89 |
| 52 Week High | $55.65 | $6.66 |
| Indicator | NNNN | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 41.14 |
| Support Level | $19.53 | $3.14 |
| Resistance Level | $30.70 | $4.17 |
| Average True Range (ATR) | 1.97 | 0.20 |
| MACD | 0.41 | 0.08 |
| Stochastic Oscillator | 84.48 | 63.45 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.